ATE552031T1 - Pharmazeutische zusammensetzungen enthaltend nicht-acyliertes ghrelin zur behandlung von insulinresistenz - Google Patents

Pharmazeutische zusammensetzungen enthaltend nicht-acyliertes ghrelin zur behandlung von insulinresistenz

Info

Publication number
ATE552031T1
ATE552031T1 AT02787266T AT02787266T ATE552031T1 AT E552031 T1 ATE552031 T1 AT E552031T1 AT 02787266 T AT02787266 T AT 02787266T AT 02787266 T AT02787266 T AT 02787266T AT E552031 T1 ATE552031 T1 AT E552031T1
Authority
AT
Austria
Prior art keywords
compositions containing
treatment
pharmaceutical compositions
insulin resistance
containing non
Prior art date
Application number
AT02787266T
Other languages
English (en)
Inventor
Ezio Ghigo
Der Lely Aart Jan Van
Original Assignee
Alize Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alize Pharma Sas filed Critical Alize Pharma Sas
Application granted granted Critical
Publication of ATE552031T1 publication Critical patent/ATE552031T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02787266T 2001-12-18 2002-12-18 Pharmazeutische zusammensetzungen enthaltend nicht-acyliertes ghrelin zur behandlung von insulinresistenz ATE552031T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2365704 2001-12-18
PCT/CA2002/001964 WO2003051389A2 (en) 2001-12-18 2002-12-18 Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof

Publications (1)

Publication Number Publication Date
ATE552031T1 true ATE552031T1 (de) 2012-04-15

Family

ID=4170909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02787266T ATE552031T1 (de) 2001-12-18 2002-12-18 Pharmazeutische zusammensetzungen enthaltend nicht-acyliertes ghrelin zur behandlung von insulinresistenz

Country Status (7)

Country Link
US (1) US7485620B2 (de)
EP (1) EP1455814B1 (de)
JP (1) JP4562394B2 (de)
AT (1) ATE552031T1 (de)
AU (1) AU2002351593A1 (de)
ES (1) ES2383796T3 (de)
WO (1) WO2003051389A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666833B2 (en) 2001-12-18 2010-02-23 Alizé Pharma SAS Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
RU2325202C2 (ru) * 2002-07-19 2008-05-27 Цитос Байотекнолоджи Аг Конъюгаты грелин-носитель
CA2543507C (en) * 2003-10-24 2012-05-01 Theratechnologies Inc. Use of ghrelin and unacylated ghrelin compositions in insulin-related disease conditions
JP2007532495A (ja) * 2004-04-07 2007-11-15 ガストロテック・ファルマ・アクティーゼルスカブ グレリン欠乏を治療するための分泌促進薬の使用
CA2587627A1 (en) * 2004-11-15 2006-05-26 Eli Lilly And Company Desacyl ghrelin antibodies and therapeutic uses thereof
JP4843827B2 (ja) * 2005-02-23 2011-12-21 国立大学法人京都大学 膵臓β細胞の再生促進剤及び膵臓β細胞におけるインスリン産生促進剤
EP1757290A1 (de) 2005-08-16 2007-02-28 Zentaris GmbH Triazolderivate als Liganden der Wachstumshormonrezeptoren
DK1937262T3 (da) * 2005-09-29 2019-07-15 Ipsen Pharma Sammensætning til anvendelse i behandling af gastrointestinal dysmotilitet
EP1818061A1 (de) * 2005-12-02 2007-08-15 Charite-Universitätsmedizin Berlin Verwendung von Ghrelin zur Stimulierung des Haarwachstums
US8653022B2 (en) 2006-03-28 2014-02-18 Liat Mintz Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
US8889632B2 (en) 2007-01-31 2014-11-18 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
EP2508531B1 (de) 2007-03-28 2016-10-19 President and Fellows of Harvard College Geheftete Polypeptide
ES2538111T3 (es) 2007-05-31 2015-06-17 Alizé Pharma SAS Grelina no acilada como agente terapéutico en el tratamiento de trastornos metabólicos
US8318664B2 (en) 2007-05-31 2012-11-27 Alize Pharma Sas Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity
EP2067481A1 (de) 2007-12-03 2009-06-10 Charité-Universitätsmedizin Berlin Therapeutische Verwendung von Desacylghrelin
US8476408B2 (en) * 2008-06-13 2013-07-02 Alize Pharma Sas Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
EP4733396A2 (de) 2009-02-26 2026-04-29 Poseida Therapeutics, Inc. Hyperaktive huckepackazibac-transposasen
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
EP2431035A1 (de) 2010-09-16 2012-03-21 Æterna Zentaris GmbH Neue Triazolderivate mit verbesserter Rezeptoraktivität und Bioverfügbarkeitseigenschaften als Ghrelin-Antagonisten der Wachstumshormon-Sekretagogum-Rezeptoren
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
LT2790721T (lt) 2011-12-15 2019-02-11 Millendo Therapeutics Sas Neacilinto grelino fragmentai, skirti naudoti preiderio-vilio sindromo gydymui
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
WO2014203074A2 (en) 2013-06-21 2014-12-24 Alize Pharma Sas Use of unacylated ghrelin, fragments and analogs thereof as antioxidant
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001228325A1 (en) 2000-02-01 2001-08-14 Novo-Nordisk A/S Use of compounds for the regulation of food intake
EP1286697A2 (de) 2000-05-17 2003-03-05 Eli Lilly And Company Methode zur selektiven hemmung der aktivität von ghrelin
CA2470235C (en) 2001-12-18 2012-02-07 Theratechnologies Inc. Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
JP5000848B2 (ja) 2002-05-21 2012-08-15 第一三共株式会社 グレリン含有医薬組成物
CA2543507C (en) 2003-10-24 2012-05-01 Theratechnologies Inc. Use of ghrelin and unacylated ghrelin compositions in insulin-related disease conditions

Also Published As

Publication number Publication date
US7485620B2 (en) 2009-02-03
EP1455814A2 (de) 2004-09-15
JP4562394B2 (ja) 2010-10-13
EP1455814B1 (de) 2012-04-04
WO2003051389A3 (en) 2003-09-12
US20050080007A1 (en) 2005-04-14
AU2002351593A1 (en) 2003-06-30
JP2005511771A (ja) 2005-04-28
WO2003051389A2 (en) 2003-06-26
ES2383796T3 (es) 2012-06-26

Similar Documents

Publication Publication Date Title
AU2002351593A1 (en) Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof
MY145590A (en) Phenylacetamides and their use as glucokinase modulators
PT1112275E (pt) Novos inibidores heteroaromaticos da frutose-1,6-bisfosfatase
AU2002305450A1 (en) Proteomimetic compounds and methods
WO2007128817A3 (en) Insulin derivative
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE503490T1 (de) Monodisperse mischungen und verfahren zur behandlung von diabetes
GB0222495D0 (en) Compounds
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
DE60028970D1 (de) An her2 bindende peptidverbindungen
TW200612987A (en) Combination treatment for non-hematologic malignancies
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
WO2003075850A3 (en) Methods for alzheimer's disease treatment and cognitive enhancement
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
CY1112184T1 (el) Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
ATE368455T1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
SE0102147D0 (sv) New methods
DE50210906D1 (de) Arzneimittel enthaltend deuterium zur behandlung der zuckerkrankheit
ATE410155T1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
AU2003260436A1 (en) Pyrimidine compounds
DK1605957T3 (da) Anvendelse af lupin-konglutin til behandling af type II-diabetes
DK1675611T3 (da) Terapeutiske anvendelser for C-peptid